DailyMarketMovers.com
news-details
Consumer,Utilities,Other Sectors

Earnings Report: 7 Stocks Expected to Report Earnings Soon

November 09, 2023 (Earnings Report)Dear Reader,We just identified several stocks that are expected to release earnings very soon.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.


Real Good Food Company, Inc. Class A
Symbol: RGF
Recent Price: $1.78
Average Analyst Price Target: $7.33 (311.80%)
Market Cap: $71.32M
Last Year's EPS: 0.03
Consensus EPS Forecast: -0.27
Expected Earnings Date: 2023-08-14

Recent Analyst Action: Bill Chappell, analyst at Truist Financial, reiterates coverage on Real Good Food Company, Inc. Class A (RGF) in the Consumer Defensive sector with a Buy rating and a price target of $4 (3 weeks ago). 

TipRanks.com also reports that Real Good Food Company, Inc. Class A currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.33 . The target pricing ranges from a high forecast of $7 down to a low forecast of $11. Real Good Food Company, Inc. Class A (RGF)’s last closing price was $1.78  which would put the average price target at 311.80% upside.

Here are 3rd party ratings for RGF:

  • TipRanks.com: Strong Buy
  • TradingView.com:
  • Yahoo! Finance: Bearish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Hold, Bottom 38% (152 out of 247)
Click for chart >>
--------------------------------------------------------------------------

Ocuphire Pharma
Symbol: OCUP
Recent Price: $3.04
Average Analyst Price Target: $20.40 (533.22%)
Market Cap: $67.44M
Last Year's EPS: -0.28
Consensus EPS Forecast: -0.36
Expected Earnings Date: 2023-08-11

Recent Analyst Action: John Newman, analyst at Canaccord Genuity, reiterates coverage on Ocuphire Pharma (OCUP) in the Healthcare sector with a Buy rating and a price target of $22 (6 days ago). 

TipRanks.com also reports that Ocuphire Pharma currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $20.40 . The target pricing ranges from a high forecast of $25 down to a low forecast of $17. Ocuphire Pharma (OCUP)’s last closing price was $3.04  which would put the average price target at 533.22% upside.

Here are 3rd party ratings for OCUP:

  • TipRanks.com: Strong Buy
  • TradingView.com:
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Buy, Top 26% (65 out of 247)
Click for chart >>
--------------------------------------------------------------------------

Jasper Therapeutics
Symbol: JSPR
Recent Price: $0.80
Average Analyst Price Target: $6.37 (773.04%)
Market Cap: $88.64M
Last Year's EPS: -0.16
Consensus EPS Forecast: -0.13
Expected Earnings Date: 2023-08-11

Recent Analyst Action: Tim Chiang, analyst at Capital One Financial, reiterates coverage on Jasper Therapeutics (JSPR) in the Healthcare sector with a Buy rating and a price target of $7 (2 months ago). 

TipRanks.com also reports that Jasper Therapeutics currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.37 . The target pricing ranges from a high forecast of $8 down to a low forecast of $4. Jasper Therapeutics (JSPR)’s last closing price was $0.80  which would put the average price target at 773.04% upside.

Here are 3rd party ratings for JSPR:

  • TipRanks.com: Moderate Buy
  • TradingView.com:
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Hold, Top 26% (65 out of 247)
Click for chart >>
--------------------------------------------------------------------------

Interlink Electronics
Symbol: LINK
Recent Price: $10.91
Average Analyst Price Target: $21.00 (92.43%)
Market Cap: $58.15M
Last Year's EPS: -0.0289
Consensus EPS Forecast: -0.07
Expected Earnings Date: 2023-08-10

Recent Analyst Action: Vijay Rakesh, analyst at Mizuho Securities, reiterates coverage on Interlink Electronics (LINK) in the Consumer Cyclical sector with a Buy rating and a price target of n/a (3 weeks ago). 

TipRanks.com also reports that Interlink Electronics currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $21.00 . The target pricing ranges from a high forecast of $21 down to a low forecast of $21. Interlink Electronics (LINK)’s last closing price was $10.91  which would put the average price target at 92.43% upside.

Here are 3rd party ratings for LINK:

  • TipRanks.com: Moderate Buy
  • TradingView.com:
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: hold
  • Zacks.com: n/a, n/a
Click for chart >>
--------------------------------------------------------------------------

Tonix Pharma
Symbol: TNXP
Recent Price: $0.49
Average Analyst Price Target: $9.00 (1940.82%)
Market Cap: $13.07M
Last Year's EPS: -3.25
Consensus EPS Forecast: -2.78
Expected Earnings Date: 2023-08-10

Recent Analyst Action: Robert LeBoyer, analyst at Noble Financial, reiterates coverage on Tonix Pharma (TNXP) in the Healthcare sector with a Buy rating and a price target of $10 (2 months ago). 

TipRanks.com also reports that Tonix Pharma currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $9.00 . The target pricing ranges from a high forecast of $8 down to a low forecast of $10. Tonix Pharma (TNXP)’s last closing price was $0.49  which would put the average price target at 1940.82% upside.

Here are 3rd party ratings for TNXP:

  • TipRanks.com: Moderate Buy
  • TradingView.com:
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: n/a, n/a
Click for chart >>
--------------------------------------------------------------------------

Algonquin Power & Utilities
Symbol: AQN
Recent Price: $5.62
Average Analyst Price Target: $7.30 (35.41%)
Market Cap: $3.89B
Last Year's EPS: 0.17
Consensus EPS Forecast: 0.1
Expected Earnings Date: 2023-08-10

Recent Analyst Action: Neil Kalton, analyst at Wells Fargo, reiterates coverage on Algonquin Power & Utilities (AQN) in the Utilities sector with a Buy rating and a price target of $8 (1 week ago). 

TipRanks.com also reports that Algonquin Power & Utilities currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $7.30 . The target pricing ranges from a high forecast of $8.5 down to a low forecast of $6. Algonquin Power & Utilities (AQN)’s last closing price was $5.62  which would put the average price target at 35.41% upside.

Here are 3rd party ratings for AQN:

  • TipRanks.com: Hold
  • TradingView.com:
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Sell, Top 27% (67 out of 247)
Click for chart >>
--------------------------------------------------------------------------

Sky Harbour Group
Symbol: SKYH
Recent Price: $6.95
Average Analyst Price Target: $11.00 (58.27%)
Market Cap: $390.71M
Last Year's EPS: -0.41
Consensus EPS Forecast: n/a
Expected Earnings Date: 2023-08-14

Recent Analyst Action: Michael Diana, analyst at Maxim Group, reiterates coverage on Sky Harbour Group (SKYH) in the Real Estate sector with a Buy rating and a price target of $11 (3 weeks ago). 

TipRanks.com also reports that Sky Harbour Group currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $11.00 . The target pricing ranges from a high forecast of $11 down to a low forecast of $11. Sky Harbour Group (SKYH)’s last closing price was $6.95  which would put the average price target at 58.27% upside.

Here are 3rd party ratings for SKYH:

  • TipRanks.com: Moderate Buy
  • TradingView.com:
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong buy
  • Zacks.com: n/a, n/a
Click for chart >>
--------------------------------------------------------------------------


To Your Financial Future,

The Editor, WallStreetSectors.com